Latest National Institute for Health and Clinical Excellence Stories
PATIENTS may get independent advice on medicine too costly for the NHS so they can buy it privately.
By Jeremy Laurance Patients cannot rely on the NHS to save their lives if the cost of doing so is too great, the Government's medicines watchdog has ruled for the first time.
PATIENTS with rare cancers are being left to die because of a postcode lottery over who gets access to drugs, research out today suggests. A study from the Rarer Cancers Forum found wide variations across England in the number of patients granted access to medicines.
BRITAIN'S National Health Service comes under intense scrutiny, but it remains the envy of the world. The principle of free treatment for all is one which has stood proud since the NHS was created 60 years ago.
Patients with rare cancers are being left to die due to a postcode lottery over who gets access to drugs, research out today suggests. A study from the Rarer Cancers Forum found wide variations across England in the number of patients granted access to medicines.
COVENTRY health chiefs are supporting a draft decision to reject four new cancer drugs for patients with advanced kidney cancer. The National Institute for Health and Clinical Excellence (Nice) decided that sunitinib, bevacizumab, sorafenib and Torisel are not a cost-effective use of NHS cash.
By Barry Nelson A CANCER patient who has survived in the past year because of a wonder drug has condemned plans to deny it to other patients because of the cost. Stan Craddock, 63, from Darlington, said he survived the past ten months because of the drug Sutent.
Britain's National Health Service said it rejected four new drugs designed to treat advanced kidney cancer because the cost is too high.
By Ian Johnston CAMPAIGNERS EXPRESSED outrage yesterday at a decision to deny four drug treatments to NHS patients with advanced kidney cancer.
By JEREMY LAURANCE The big question Why are we asking this now? CANCER CHARITIES, kidney specialists and campaigners were outraged yesterday when the National Institute for Clinical Excellence (Nice), announced that it had rejected four new drugs for advanced kidney cancer as too expensive for the NHS.
- To writhe; struggle or twist about with more or less force; wriggle.
- To scribble, jot.